ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 890 filers reported holding ISHARES TR in Q4 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,455,130 | +3.1% | 20,206 | +7.8% | 0.03% | +6.5% |
| Q2 2023 | $2,381,217 | +15.2% | 18,749 | +16.9% | 0.03% | +19.2% |
| Q1 2023 | $2,067,354 | +138.6% | 16,039 | +141.5% | 0.03% | +100.0% |
| Q4 2022 | $866,461 | -62.4% | 6,642 | -66.2% | 0.01% | -64.9% |
| Q3 2022 | $2,307,000 | +34.1% | 19,640 | +34.6% | 0.04% | +42.3% |
| Q2 2022 | $1,720,000 | -42.4% | 14,591 | -35.3% | 0.03% | -35.0% |
| Q1 2022 | $2,987,000 | +42.4% | 22,546 | +65.5% | 0.04% | +42.9% |
| Q4 2021 | $2,098,000 | +64.5% | 13,625 | +72.8% | 0.03% | +40.0% |
| Q3 2021 | $1,275,000 | +3.1% | 7,883 | +4.3% | 0.02% | -9.1% |
| Q2 2021 | $1,237,000 | -57.9% | 7,557 | -61.3% | 0.02% | -62.1% |
| Q1 2021 | $2,936,000 | +11.0% | 19,523 | +11.7% | 0.06% | -6.5% |
| Q4 2020 | $2,646,000 | -35.0% | 17,473 | -41.9% | 0.06% | -47.5% |
| Q3 2020 | $4,073,000 | +232.5% | 30,083 | +235.5% | 0.12% | +202.6% |
| Q2 2020 | $1,225,000 | +390.0% | 8,967 | +285.5% | 0.04% | +333.3% |
| Q1 2020 | $250,000 | – | 2,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |